1. Home
  2. TLRY vs YDES Comparison

TLRY vs YDES Comparison

Compare TLRY & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilray Brands Inc.

TLRY

Tilray Brands Inc.

HOLD

Current Price

$4.03

Market Cap

560.3M

Sector

Health Care

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$7.04

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLRY
YDES
Founded
N/A
2013
Country
Canada
Taiwan
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.3M
543.0M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
TLRY
YDES
Price
$4.03
$7.04
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $72.33
N/A
AVG Volume (30 Days)
★ 3.1M
701.4K
Earning Date
04-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.69
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$8.79
N/A
Revenue Next Year
$19.98
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$1.70
52 Week High
$15.70
$22.00

Technical Indicators

Market Signals
Indicator
TLRY
YDES
Relative Strength Index (RSI) 41.49 74.07
Support Level $3.87 $1.99
Resistance Level $4.91 $9.11
Average True Range (ATR) 0.15 0.82
MACD 0.00 0.26
Stochastic Oscillator 31.18 95.52

Price Performance

Historical Comparison
TLRY
YDES

About TLRY Tilray Brands Inc.

Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: